All data are based on the daily closing price as of October 8, 2025
e
Eiken Chemical
4549.TSE
15.61 USD
-0.34
-2.13%
Overview
Last close
15.61 usd
Market cap
514.75M usd
52 week high
17.03 usd
52 week low
12.54 usd
Target price
13.75 usd
Valuation
P/E
37.5623
Forward P/E
N/A
Price/Sales
1.9287
Price/Book Value
1.8723
Enterprise Value
509.50M usd
EV/Revenue
1.92
EV/EBITDA
13.9942
Key financials
Revenue TTM
269.80M usd
Gross Profit TTM
109.07M usd
EBITDA TTM
35.96M usd
Earnings per Share
0.42 usd
Dividend
0.35 usd
Total assets
412.91M usd
Net debt
-11.58M usd
About
Eiken Chemical Co., Ltd. engages in the manufacture and sale of clinical diagnostics in Japan. It offers microbiological reagents for diagnosis of microorganism infection, such as mediums, antimicrobial susceptibility, and rapid test reagents; urinalysis test strips for occult blood, protein, and glucose; and fecal immunochemical tests reagents for screening of colorectal cancer. The company also provides immunological and serological reagents to detect and monitor infectious disease, rheumatism, inflammation, atrophic gastritis, and prostate specific antigens; and clinical chemistry tests to measure and analyze biological components in blood serum and urine. In addition, it sells reagents and devices of microbiological test for food poisoning bacteria and environmental inspection; and offers nucleic acid amplification method, as well as provides various types of automated analyzers. The company was formerly known as Nihon Eiyokagaku Co., Ltd. and changed its name to Eiken Chemical Co., Ltd. in 1969. Eiken Chemical Co., Ltd. was incorporated in 1939 and is headquartered in Tokyo, Japan.